BRAND_ANALYSIS#JOHNSON_AND_JOHNSONHEALTH & PHARMA#3 OF 26 IN HEALTH & PHARMAINTERESTING
Johnson & Johnson
· Public · Updated 25 May 2026 11:16 UTC
#52 of 1208 overall by tension · #3 of 26 in Health & Pharma
27Interesting
The Silent Giant
Analysis
J&J carries C=55 and sentiment of 0.50 through the permanent background radiation of talc litigation and brand spinoffs. The 1.6% stock gain is steady as a pharmaceutical dividend should be. It's a company that has weaponized trustworthiness so thoroughly that no single controversy can fully dislodge the halo.
IN THE NEWS (100 articles this week)
Johnson & Johnson | History, Products, & Controversies - Britannica
Zion Johnson and O-line focused on assignments, technique and execution in OTAs | OTAs & Minicamp - Cleveland Browns
Morez Johnson Jr., ex-Michigan star, to keep name in NBA draft - ESPN